Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Gambro is reminding users of the importance of following the instructions in the operating manual when alarm 642 "arterial chamber level adjustment required" occurs which indicates low blood level in the arterial chamber. gambro has become aware of events where the instructions have not been followed and this may deactivate the alarm mechanism. the manual provides instructions on how to increase the blood level and advises that if the reset buton is pressed without adjusting the blood level the alarm will no longer be triggered during the remaining treatment time. performing the treatment with blood level too low in the arterial chamber may result in microbubbles smaller than 20 micro litres reaching the patient.